Kawajiri, A
Maruyama, D
Maeshima, A M
Nomoto, J
Makita, S
Kitahara, H
Miyamoto, K-i
Fukuhara, S
Suzuki, T
Munakata, W
Tajima, K
Itami, J
Taniguchi, H
Kobayashi, Y
Tobinai, K
Article History
First Online: 30 September 2016
Competing interests
: KY has received funding from Otsuka Pharmaceutical Co., Ltd, ARIAD Pharmaceuticals, Inc., Boehringer Ingelheim GmbH. TK, Zenyaku Kogyo has received funding from Chugai Pharmaceutical. The remaining authors declare no conflict of interest.